Clinical Trial Update: Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis [Phase 3]

View source ↗

Summary

A Phase 3 trial of cinacalcet HCl in chronic kidney disease patients with secondary hyperparathyroidism not on dialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• Cinacalcet HCl (cinacalcet hydrochloride)

Snippet

Sponsor: Amgen | Conditions: Kidney Disease, Chronic Kidney Disease | Phase 3 | Status: COMPLETED